Palmetto
Adaptive Biotechnologies Test Receives Expanded Medicare Coverage for Mantle Cell Lymphoma
The firm's blood-based ClonoSeq test can be used to assess response to treatment, understand prognosis, and monitor patients to detect molecular recurrence.
Cofactor Genomics Immunotherapy Response Test Nabs Medicare Coverage
The assay evaluates a patient's tumor immune profile against Cofactor's high-dimensional RNA-based Health Expression Models to predict a patient's therapy response.
Local Coverage Determinations Roundup: Veracyte, Sonic Healthcare USA
A roundup of local coverage determinations from Medicare administrative contractors.
Local Coverage Determinations Roundup: Veracyte
A roundup of local coverage determinations from Medicare administrative contractors.
Palmetto Declines to Cover Molecular Risk Stratification Tests for Cutaneous Squamous Cell Carcinoma
The three other Medicare administrative contractors that participate in the MolDx program aligned their coverage with Palmetto's.
Jan 3, 2024
Jul 13, 2023
Dec 8, 2022